Over marketing to Medicare...BD
To do so, prosecutors must show that a whistle-blower was the planner or initiator of the scheme involved; otherwise he or she is legally entitled to receive 15 to 25 percent of any funds recovered by the government. The precise figure is determined by a whistle-blower’s contribution to the case.
In a ruling after a two-day hearing last month in Seattle, Judge Marsha J. Pechman of Federal District Court found that prosecutors had failed to prove that Mr. Marchese was the initiator of a scheme at his former employer, Cell Therapeutics. In April, the company agreed to pay $10.5 million to settle charges that it had bilked Medicare out of that much money in connection with the sale of a cancer drug, Trisenox.
0 comments :
Post a Comment